Escitalopram Oxalate
Product Images NDC 70934-089

6 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 70934-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 01)

1 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 01)
Data table showing treatment-emergent adverse reactions with escitalopram oxalate versus placebo for Major Depressive Disorder. It lists adverse reactions by system, including nervous, gastrointestinal, general, psychiatric, respiratory, and urogenital disorders, with percentages for each group. Notes clarify denominators for male and female subgroups.*
FDA Label Image

2 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 02)

2 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 02)
A data table titled 'TABLE 3' listing treatment-emergent adverse reactions observed with a frequency of 2% or greater and greater than placebo for escitalopram oxalate versus placebo in generalized anxiety disorder. It categorizes adverse reactions by systems such as autonomic nervous system, central and peripheral nervous system, gastrointestinal, general, musculoskeletal, psychiatric, respiratory, and urogenital disorders, with percentages for escitalopram oxalate (N=429) and placebo (N=427).*
FDA Label Image

1 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 03)

1 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 03)
Chemical structure of escitalopram oxalate, showing its molecular configuration as part of the active ingredient in the product labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals.*
FDA Label Image

Logo (A659eec9 07cf 4399 Abab 7e8036d8b6ad 04)

FDA Label Image

1 (A659eec9 07cf 4399 Abab 7e8036d8b6ad 05)

FDA Label Image

Label (70934 089 90 Master Bottle Label Approval Rev A 01 19)

Label (70934 089 90 Master Bottle Label Approval   Rev A 01 19)
Escitalopram Tablets, USP 20 mg bottle label showing NDC 70934-089-90. The label states a quantity of 90 tablets, prescription only, storage instructions, and packaging details by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. It includes barcode, repackage info, and manufacturing identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.